FRAGMENT-BASED DRUG DESIGN TO INHIBIT DNA METHYLTRANSFERASE 1 (DNMT1) FOR BREAST CANCER THERAPY. GEOMATE Journal, [S. l.], v. 17, n. 62, p. 35–40, 2019. Disponível em: https://geomatejournal.com/geomate/article/view/593. Acesso em: 17 apr. 2026.